Park Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
4,189
-346
-8% -$80.6K 0.63% 39
2026
Q1
$1.11M Sell
4,535
-495
-10% -$115K 1.08% 14
2025
Q4
$1.04M Sell
5,030
-452
-8% -$89.4K 0.75% 30
2025
Q3
$1.02M Sell
5,482
-154
-3% -$26.4K 0.81% 25
2025
Q2
$861K Sell
5,636
-729
-11% -$112K 0.8% 25
2025
Q1
$1.06M Buy
6,365
+125
+2% +$19.6K 1.23% 13
2024
Q4
$902K Buy
+6,240
New +$967K 1.08% 18

Other funds holding JNJ

Park Capital Management's JNJ Position: Q2 2026 in Review

Park Capital Management reduced its Johnson & Johnson (JNJ) stake by 7.6% in Q2 2026, selling an estimated $80.6K and leaving 4,189 shares worth $1.06M. The position accounts for 0.63% of the portfolio, ranked #39.

Park Capital Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.11M in Q1 2026. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Park Capital Management held 4,189 shares of Johnson & Johnson worth $1.06M as of Q2 2026.
  • Park Capital Management sold 346 Johnson & Johnson shares in Q2 2026, an estimated $80.6K.
  • Johnson & Johnson made up 0.63% of Park Capital Management's portfolio in Q2 2026, its #39 holding.
  • Park Capital Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Park Capital Management's Johnson & Johnson position peaked at $1.11M in Q1 2026.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Park Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.